← Evidence map

ArticleFrontiers in oncology2022

Intermittent MEK inhibition for the treatment of metastatic uveal melanoma.

Shaheer Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36249046